For research use only
| Cat No. | ABC-X0270C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocytes |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The human FGFR3_BAIAP2L1 BAF3 Cell Line supports detailed studies on FGFR3 fusion-driven signaling pathways and cancer therapeutic targets.
Human FGFR3_BAIAP2L1 BAF3 Cell Line is a genetically engineered model based on murine BAF3 cells expressing the FGFR3-BAIAP2L1 fusion construct. Integration is achieved by lentiviral transduction, and expression is validated by qRT-PCR.
Target
The FGFR3-BAIAP2L1 fusion leads to constitutive activation of FGFR3 kinase signaling and has been implicated in multiple cancers including bladder carcinoma. It promotes oncogenesis via PI3K/AKT and MAPK pathways. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0270C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocytes |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
This model is used for functional analysis of FGFR3 fusions, screening of FGFR inhibitors, and studying oncogenic pathways driven by fusion kinases.